首页 / 院系成果 / 成果详情页

Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia 会议论文 期刊论文

编号：

18888353-c07a-49b5-becf-a19243517e83
作者：

Luedtke, Daniel A.#^[1]Su, Yongwei^[2];Edwards, Holly^[3];Polin, Lisa^[3];Kushner, Juiwanna^[3];Dzinic, Sijana H.^[3];Lin, Hai(林海)^[4]Taub, Jeffrey W.^[5];Ge, Yubin^[3];
语种：

英文
期刊：

BLOOD ISSN：0006-4971 2018 年 132 卷 ; NOV 29
收录：
推荐引用方式
GB/T 7714：

Luedtke Daniel A.,Su Yongwei,Edwards Holly, et al. Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia [J].BLOOD,2018,132.
APA：

Luedtke Daniel A.,Su Yongwei,Edwards Holly,Polin Lisa,&Ge Yubin.(2018).Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia .BLOOD,132.
MLA：

Luedtke Daniel A., et al. "Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia" .BLOOD 132(2018).
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：94  下载次数：0

浏览次数：94

下载次数：0

打印次数：0

Voruciclib, an Oral, Selective CDK9 Inhibitor, Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor Venetoclax in Acute Myeloid Leukemia 会议论文期刊论文